Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Fertility

 

Eugin process enters second-round – but will COVID impact valuation?

Sell-side advisors Perella Weinburg have shortlisted a dozen second-rounder bidders for Eugin, the global IVF arm of NMC Health, according to reports in Spain. A source tells HBI Eugin's recent figures have been significantly impacted by COVID - will it impact the valuation?

PWC on M&A drivers in Spanish healthcare sector

The Spanish private healthcare market has been one of Europe's most attractive for institutional investors of late with strong organic and inorganic growth opportunities. PWC Spain's deals leader for Healthcare & Pharma Jose Zarzalejos talks us through the drivers, movers and shakers in the six main sub-sectors: hospitals, imaging, oncology, care homes, IVF and dentistry.

What does a good post-COVID outpatient clinic look like?

Outpatient activity all but came to a standstill as the COVID crisis tightened its grip. A panel of experts comprising Richard Banks, Chief Strategy Officer at international fertility player Virtus Health, Martin Bundschu, Director at Germany-based optical specialist Smile Eyes, former Colosseum Dental CEO Tomas Aubell, and L.E.K. Consulting's global co-head of healthcare Ben Faircloth joined an HBI-365 audience last week to discuss what a good outpatient clinic post-COVID might look like, and how markets have been affected.

Adding value post-COVID – where are the easy wins?

How do you add value to a business in a post COVID world - and are there any easy wins for new acquisitions? On Wednesday last week, an online audience heard HBI365's lively Q&A panel with with Ameos CEO Dr Axel Paeger, McKinsey partner Sebastian Sieler, and L Catterton managing partner Chinta Bhagat.

Outpatient models post-Covid

Join us to hear from our expert panel address and to share your own experiences. You will be seeing · Richard Banks, Chief Strategy Officer, Virtus Health · Martin Bundschu, Director, Smile Eyes · Tomas Aubell, MD Cosmea Pflege Holding, former CEO Colosseum Dental and ex Jacobs Chief Investment Officer · Ben Faircloth, global co-head of L.E.K. Consulting’s healthcare […]

Health care values look high

Analyst forecasts suggest that healthcare sector valuations have been largely unaffected by the crisis, with EMEA hospitals and medtech stocks now being more expensive than before the Covid outbreak, both on an EBITDA and PE multiples basis.

NMC on the verge of liquidation as investors await ‘fire sale’

The administrators appointed to oversee GCC-based and formerly London-listed NMC Health PLC say it is facing likely liquidation or dissolution, and ongoing investigations must be completed to ascertain the company's true liabilities. A sale of the business as a going concern is now all but off the table. Meanwhile, HBI hears potential buyers for the most prized parts of the business are waiting for a rock bottom price 'fire sale'.

Find Us